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Thixotropy conditioning of inspiratory muscles at lower lung volumes decreases functional
residual capacity (FRC) of following breath cycles with increases in inspiratory capacity. It
remains uncertain whether this conditioning would improve exercise tolerance in chronic
obstructive pulmonary disease (COPD).
Sixteen male stable COPD patients with mild to severe airway obstruction participated.
Before the study, all patients completed the 6-min walk test at least twice. The 6-min walk
distance (6MWD) was measured after single inspiratory muscle training (IMT) maneuver or
without intervention (control) in a randomized cross-over fashion. The 6MWD was also
measured after thixotropy conditioning of inspiratory muscles at the maximal expiratory
position or without intervention (control).
There were no signiﬁcant differences in the 6MWD after the IMT maneuver (493.2783.7m,
P40.05) versus without intervention (495.7785.9m). The 6MWD after thixotropy
conditioning (526.2796.3m, P ¼ 0.030) was signiﬁcantly higher than the 6MWD without
intervention (504.3794.1m). The 95% conﬁdence interval of the difference was from 2.6
to 41.2m. Percentage predicted FRC correlated positively with differences in the 6MWD
between control and after the thixotropy conditioning maneuver (r ¼ 0.78, P ¼ 0.007),
whereas percentage predicted forced expiratory volume in 1 s or the BODE index did not
correlate with differences in the 6MWD (P40.05).
Thixotropy conditioning increases self-paced walking distance in patients with COPD.
Patients with higher resting FRC beneﬁted more from the conditioning with greater
walking distance.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Skeletal muscle ﬁbers possess a biophysical property
referred to as thixotropy, by which passive stiffness of a
muscle depends on whether the muscle was contracted
immediately beforehand at a long length (hold-long con-
ditioning) or at a short length (hold-short conditioning).1,2
This process increases the stiffness and resting tension
of the muscle under hold-short conditioning, while it
decreases the stiffness of the muscle under hold-long
conditioning. The original basic observations concerning
muscle thixotropy were made on relaxed frog muscle ﬁbers,
and subsequently muscle thixotropy of human limb muscles
has been investigated. Homma and Hagbarth3 identiﬁed
respiratory muscle thixotropy and since then we have
reported that respiratory muscle conditioning based on the
principles of muscle thixotropy acutely alters functional
residual capacity (FRC).3–8
Lung hyperinﬂation is an important physiologic abnorm-
ality in patients with chronic obstructive pulmonary disease
(COPD).9,10 A reduction in elastic recoil of the lung statically
increases FRC, and lung hyperinﬂation progresses dynami-
cally during exercise because of a limitation in expiratory
ﬂow. Lung hyperinﬂation increases the operating lung
volumes and places inspiratory muscles at a mechanical
disadvantage, contributing to the occurrence of dyspnea
and limiting exercise capacity in these patients.10
Thixotropy conditioning of inspiratory muscles at lower
lung volumes, which corresponds to hold-long conditioning
of the muscles, is followed by decreases in FRC with
increases in inspiratory capacity (IC) and also inspiratory
reserve volume (IRV).4,6,11 However, it remains unclear
whether this conditioning would lead to improved clinical
outcomes. Therefore, we undertook the present study to
determine the immediate effects of conditioning on
exercise tolerance in patients with mild to severe COPD,
using the 6-min walk test (6MWT). We also performed
correlation analysis to characterize which patients would
beneﬁt most from the conditioning, if at all. We hypothe-
sized that inspiratory muscle conditioning at lower lung
volumes prior to exercise would improve the 6-min walk
distance (6MWD) in patients with COPD.
Materials and methods
Patients
Sixteen clinically stable male outpatients with COPD agreed
to participate in the study. Inclusion criteria included the
following: (1) current or former smoker (410 pack-years);
(2) post-bronchodilator forced expiratory volume in 1 s
(FEV1)/forced vital capacity (FVC) ratio o70%; (3) opti-
mized medical treatment. Exclusion criteria included the
following: (1) clinical evidence of exercise limiting cardio-
vascular or neuromuscular diseases; (2) exacerbations in the
preceding 4 weeks; or (3) an inability to communicate. All
patients had been referred to the Outpatient Pulmonary
Rehabilitation Clinic at Akita City Hospital. The rehabilita-
tion program consisted mainly of education sessions and
low-intensity exercise training once weekly or biweekly at
the hospital. Walking, breathing retraining, and stretchingexercises at home to supplement the formal sessions were
encouraged.
This study consisted of two experiments. Experiment 1
was aimed to determine the acute effects of the inspiratory
muscle training (IMT) maneuver on the 6MWD. Experiment 2
was performed to determine acute effects of thixotropy
conditioning of inspiratory muscles on 6MWD. Experiments 1
and 2 were performed 12 weeks apart, and the order of the
experiments 1 and 2 was not randomized. Accordingly, the
control 6MWT was performed in each experiment. Before
entry to the study all patients completed at least two 6MWTs
(range 2–6) for reasons of medical follow-up, and they had
been familiarized with rating the modiﬁed Borg scale,
ranking magnitude from 0 (none) to 10 (maximal) to express
their dyspnea and leg discomfort. They were instructed to
continue all their medications including anticholinergics,
b2-agonists, and theophyllines. This study was approved by
the Ethics Committees of Showa University and Akita City
Hospital and it was performed in accordance with the
Declaration of Helsinki. All subjects provided written
informed consent for participation in the study.
Pulmonary function tests and baseline
measurements
All patients underwent spirometry (CHESTAC-8800, Chest,
Tokyo, Japan) according to the method described by the
ATS/ERS task force, after obtaining informed consent.12
Total lung capacity (TLC), FRC, and residual volume (RV)
were measured with the multiple-breath helium dilution
method (CHESTAC-8800). They also underwent determina-
tion of maximal inspiratory mouth pressure (MIP) at RV and
maximal expiratory mouth pressure (MEP) at TLC. Predicted
normal values for FEV1, FRC, RV, and TLC were from Nishida
et al.13,14 Functional dyspnea was assessed using the
modiﬁed Medical Research Council (MMRC) dyspnea scale,
based on ﬁve increasing grades (0–4).15 The BODE index was
also calculated in each subject.16
6MWT
Subjects were instructed to walk at their own maximal pace
along an oval-shaped, 88-m indoor, level, hospital corridor
and were told prior to 6MWT: ‘‘The object of this test is to
walk as far as possible for 6min’’ in Japanese by an
investigator. No encouragement was given, and subjects
were informed each minute of the time remaining. The
subjects were allowed to stop, but they could start again, if
possible. Chairs were placed along the corridor. Dyspnea and
leg discomfort were measured using a modiﬁed Borg scale.
The investigator asked the subject to rate the intensity of
dyspnea and leg discomfort immediately before the start of
6MWT and at the end of the test. Pulse oxyhemoglobin
saturation (SpO2) was also recorded.
Experiment 1
Apparatus
The IMT maneuver was performed using an inspiratory
threshold device (Threshold IMT, Respironics, Cedar Grove,
NJ). Subjects inspired from the maximal expiratory position
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Table 1 Mean baseline anthropometric and pulmonary
function of study subjects.
All Completer
Subjects (n) 16 10
Age (years) 75.675.4 74.274.9
Gender (male/female) 16/0 10/0
Height (m) 1.6070.04 1.6070.04
Weight (kg) 60.2710.0 62.5711.3
BMI (kg/m2) 23.573.7 24.273.7
MMRC dyspnea score (0–4) 1.270.8 1.170.7
Smoking history (pack-
years)
75.6734.0 77.8740.8
Current smokers (n) 2 1
Chronic O2 use (n) 0 0
MIP (cmH2O) 70.4726.3 77.2719.9
MEP (cmH2O) 111.0720.1 116.6715.3
FEV1 (L) 1.5970.50 1.5770.54
FEV1 (% predicted) 73.9723.7 70.4721.3
FEV1/FVC (%) 46.4713.3 45.6713.1
IC (L) 2.1770.47 2.2070.54
ERV (L) 1.4170.33 1.4070.38
TLC (% predicted) 116.8718.5 114.5717.9
FRC (% predicted) 127.8723.2 123.8717.5
RV (% predicted) 133.3731.4 128.2727.1
SpO2 (%) 96.671.4 96.271.5
6MWD (m) 501.1763.3 499.7770.1
BODE index 1.271.3 1.171.0
Values are means7S.D. 6MWD: 6-min walk distance, mea-
sured before entry; BMI: body mass index; ERV: expiratory
reserve volume; FEV1: forced expiratory volume in 1 s; FRC:
functional residual capacity; FVC: forced vital capacity;
IC: inspiratory capacity; MEP: maximum expiratory mouth
pressure; MIP: maximum inspiratory mouth pressure; MMRC:
modiﬁed Medical Research Council dyspnea scale (0–4),
which is used for calculation of the BODE index; RV: residual
volume; S.D.: standard deviation; SpO2: pulse oxyhemoglobin
saturation; TLC: total lung capacity.
M. Izumizaki et al.972to the maximal inspiratory position at a threshold opening
pressure of 30% of MIP.
Protocol
One 6MWTwas performed after a single IMT maneuver, and
the other was performed without a preceding IMT maneuver.
Each subject was studied on 2 separate days 2 or 4 weeks
apart. The test order was randomized by opaque sealed
envelopes for the ﬁrst day and reversed on the second day.
Subjects sat at rest in a chair, located near the starting
position for 10min. The subject was then directed to
perform or not to perform the IMT maneuver by an
investigator. The 6MWT was started 1min after the single
IMT maneuver, or after a 2-min-rest period when the IMT
maneuver was not performed.
Experiment 2
Apparatus
A device designed to perform thixotropy conditioning of
respiratory muscles enabled the subject to perform this
conditioning (ChestTrainer, CHEST M.I., Tokyo, Japan).4 The
apparatus consisted of a portable spirometer equipped with
a mouthpiece shutter, which was manually triggered to close
the airway and with a pressure transducer to measure mouth
pressure. ChestTrainer data were fed into a laptop computer
and the integrated ﬂow signal was monitored online to
determine when the airway was closed by the shutter.
Thixotropy conditioning
The subject was seated on a chair with their nose clipped
and wearing a mouthpiece to which the ﬂow head of the
spirometer of ChestTrainer was attached. After ﬁve to six
tidal breaths, the subject was instructed to exhale to the
maximal expiratory position and then make an inspiratory
effort at a mouth pressure of 30% MIP at this acquired
position. The inspiratory effort was maintained for 3 s with
subsequent relaxation for 2–3 s with the airway closed. After
the conditioning maneuver, the shutter was reopened and
the subject resumed breathing. The subject was allowed to
remove their mouth from the mouthpiece after the ﬁve
subsequent breath cycles. All subjects who participated in
experiment 2 were trained to perform the thixotropy
conditioning maneuver under instruction provided by M.I.
or M.S. on a separate visit.
Protocol
One 6MWTwas performed after thixotropy conditioning, and
the other was performed without the preceding conditioning
maneuver. Each subject was studied on 2 separate days 2 or
4 weeks apart. The test order was randomized by opaque
sealed envelopes for the ﬁrst day and reversed on the
second day. The subject sat at rest in the chair for at least
10min. The subject was directed to perform or not to
perform the thixotropy conditioning maneuver before the
6MWT. The 6MWT was started 1min after the thixotropy
conditioning maneuver or after a 2-min-rest period. In this
experiment, IC was measured with ChestTrainer three times
before conditioning, and the maximum value was taken as
control in each subject. IC was also measured once
immediately after 6MWT.Statistical analysis
Results are expressed as means7S.D. Analysis was per-
formed using speciﬁc software packages (InStat, GraphPad,
San Diego, CA, and SPSS, SPSS Japan, Tokyo, Japan). The
6MWD were compared by paired t-test (InStat). Changes in
dyspnea (DDyspnea) and leg discomfort (DLeg discomfort)
during 6MWT were analyzed by Wilcoxon matched-pairs
signed-ranks test (InStat). Changes in SpO2 (DSpO2) were
analyzed by paired t-test (InStat). Changes in IC were
analyzed by two-way repeated-measures analysis of var-
iance (ANOVA) to test for within-factor (time and condition-
ing) effects, and any interaction between these two effects
(SPSS). Correlations between baseline values of FEV1 and
FRC and differences in the 6MWD were tested using Pearson
correlation (InStat). Correlations between the BODE index
and differences in the 6MWD were tested using Spearman
rank correlation (InStat). Differences in 6MWD were derived
by subtracting 6MWD without intervention (control) from
6MWD after intervention (IMT or thixotropy conditioning).
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control 6MWD, the difference was expressed as a positive
value. We also compared three 6MWDs from the 10 subjects,
who participated in both experiments 1 and 2, by one-way
repeated-measures ANOVA (InStat) to conﬁrm the reprodu-
cibility of 6MWD in the subjects: (1) last 6MWD before entry,
(2) control 6MWD in experiment 1, and (3) control 6MWD in
experiment 2. All results were tested for two-sided
signiﬁcance, and signiﬁcance was set at Po0.05. Sample
size calculations for the present study were based on
another trial,6 in which we observed the mean7S.D. for
paired differences in IC before and 6min after conditioning
of 0.1570.14 L; although the primary outcome of the
present study was the change in 6MWD. We assumed an
alpha level of 0.05. A sample size of eight subjects allowed
480% statistical power to distinguish differences from
chance alone (StatMate, GraphPad).Results
Subjects
Of the 16 subjects who participated in experiment 1, six
subjects did not participate in experiment 2 because of
acute exacerbations of COPD (n ¼ 2) or did not wish to
participate (n ¼ 4). Patient characteristics, including
anthropometric data, MMRC dyspnea score, the BODE index,
lung function variables, and the latest 6MWD before testTable 2 6-min walk test after the IMT maneuver.
Control
n ¼ 16
6MWD (m) 480.1790.5
Dyspnea at start (Borg) 0.270.4
Dyspnea at end (Borg) 2.771.7
DDyspnea (Borg) 2.571.8
Leg discomfort at start (Borg) 0.270.4
Leg discomfort at end (Borg) 1.771.7
DLeg discomfort (Borg) 1.671.5
SpO2 at start (%) 95.971.8
SpO2 at end (%) 91.475.6
DSpO2 (%) –4.674.5
Patients with SpO2o88% (n) 3
n ¼ 10
6MWD (m) 495.7785.9
Dyspnea at start (Borg) 0.370.4
Dyspnea at end (Borg) 2.971.5
DDyspnea (Borg) 2.671.6
Leg discomfort at start (Borg) 0.170.2
Leg discomfort at end (Borg) 1.371.3
DLeg discomfort (Borg) 1.371.4
SpO2 at start (%) 95.271.8
SpO2 at end (%) 89.376.1
DSpO2 (%) –5.975.1
Patients with SpO2o88% (n) 3
Values are means7S.D. 6MWD: 6-min walk distance; IMT: inspiratoryentry are presented in Table 1. The patients had a wide
range of FEV1, and disease severity ranging from mild to
severe.
Reproducibility of the 6MWD
The 6MWD of the 10 subjects, who participated in both
experiments, was reproducible under similar conditions:
499.7770.1m (before entry), 495.7785.9m (control value
in experiment 1), and 504.3794.1m (control value in
experiment 2) (P40.05, one-way ANOVA).
Effects of IMT on 6MWT
Results of experiment 1 indicate that the IMT maneuver did
not increase the mean 6MWD (Table 2). The 6MWD walked
by the 16 patients was 480.1790.5m when they received
no intervention prior to 6MWT. The distance walked by
these patients after the IMT maneuver was similar
(474.8784.8m, P40.05). The 95% conﬁdence interval of
the difference was from 22.3 to 11.7m. In the 10 patients,
who participated in both experiments 1 and 2 (completers),
there were no signiﬁcant differences in 6MWD with the IMT
maneuver (493.2783.7m, P40.05) and without interven-
tion (495.7785.9m). The 95% conﬁdence interval of the
difference was from 21.3 to 16.3m. Differences in the
DBorg dyspnea rating, DLeg discomfort rating, and DSpO2
were not signiﬁcant (Table 2).IMT P-value
474.8784.8 40.05
0.270.3
2.271.6
2.171.5 40.05
0.070.0
1.371.4
1.371.4 40.05
96.471.4
91.375.4
–5.174.4 40.05
3
493.2783.7 40.05
0.370.4
2.271.6
1.971.3 40.05
0.070.0
1.171.0
1.171.0 40.05
95.971.4
89.776.1
–6.274.9 40.05
3
muscle training; SpO2: pulse oxyhemoglobin saturation.
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Table 3 6-min walk test after thixotropy conditioning.
Control Thixotropy P-value
n ¼ 10
6MWD (m) 504.3794.1 526.2796.3 0.030
Dyspnea at start (Borg) 0.470.7 0.370.6
Dyspnea at end (Borg) 2.971.5 2.871.8
DDyspnea (Borg) 2.671.3 2.671.6 40.05
Leg discomfort at start (Borg) 0.270.3 0.270.6
Leg discomfort at end (Borg) 2.071.2 2.571.6
DLeg discomfort (Borg) 1.971.2 2.371.3 40.05
SpO2 at start (%) 95.372.0 95.671.6
SpO2 at end (%) 89.876.5 89.375.0
DSpO2 (%) –5.575.0 –6.373.8 40.05
Patients with SpO2o88% (n) 3 3
Values are means7S.D. 6MWD: 6-min walk distance; SpO2: pulse oxyhemoglobin saturation.
IC
 (L
)
Pre 6 min
*
Control
3
2
1
0
Thixotropy
Figure 1 Inspiratory capacity (IC) before (Pre) and at the end
of the 6-min walk test (6min). A signiﬁcant main effect for time
was detected by two-way analysis of variance (*P ¼ 0.008),
suggesting that lung hyperinﬂation occurred. There were no
interactions between time and conditioning effects, suggesting
that the level of lung hyperinﬂation was similar between the
control and the thixotropy conditioning maneuver.
M. Izumizaki et al.974Effects of thixotropy conditioning on 6MWT
Experiment 2 revealed improvements of the mean 6MWD
after thixotropy conditioning (Table 3). The 6MWD after
thixotropy conditioning (526.2796.3m, P ¼ 0.030) was
signiﬁcantly higher than the 6MWD without intervention
(504.3794.1m). The 95% conﬁdence interval of the
difference was from 2.6 to 41.2m. Of the 10 patients,
2 patients walked 50m longer after thixotropy conditioning
than control. Differences in the DBorg dyspnea rating, DLeg
discomfort rating, and DSpO2 were not signiﬁcant (Table 3).
A signiﬁcant main effect for time detected by two-way
ANOVA (P ¼ 0.008) showed that spirometric IC was de-
creased by 6MWT (Figure 1), suggesting that lung hyperin-
ﬂation occurred regardless of whether the subjects
underwent thixotropy conditioning or not. However, the
ANOVA did not reveal any signiﬁcant interactions between
time and conditioning effects (P40.05), suggesting that the
level of lung hyperinﬂation was similar between the control
and the thixotropy conditioning maneuver, although the
difference in 6MWD was signiﬁcant.Correlates of differences in 6MWD and baseline
FEV1, FRC, and the BODE index
Although the mean 6MWD was not increased after the IMT
maneuver, the BODE index was positively correlated with
differences in 6MWD between controls and after the IMT
maneuver in 16 subjects (Figure 2A, upper right panel).
However, there was no association between the percentage
predicted FEV1 and differences in 6MWD, or the percentage
predicted FRC and differences in 6MWD. In contrast, the
percentage predicted FRC was positively correlated with
differences in the 6MWD between the control and after the
thixotropy conditioning maneuver (Figure 2B, middle panel),
suggesting that the improvement in the 6MWD after
thixotropy conditioning was greater in patients with higher
resting FRC. The percentage predicted FEV1 or the BODE
index did not correlate with differences in 6MWD.Discussion
In the present study, we found that thixotropy conditioning
of inspiratory muscles performed prior to the 6MWT
increased the mean 6MWD in patients with COPD. Correla-
tion analyses revealed that patients with higher resting FRC
beneﬁted more from the conditioning in the 6MWT.
In this study, we used the 6MWT to determine changes in
exercise tolerance after IMT or thixotropy conditioning
maneuver because the 6MWT is widely used to assess
functional status in patients with COPD. The advantages of
the test compared with formal exercise testing, such as
ergometry or treadmill exercise, are that it is a practical
simple test and does not require advanced training for
technicians. We acknowledge that the self-paced 6MWT
assesses the submaximal level of functional capacity.
Although the 6MWT does not determine peak oxygen uptake,
it may better reﬂect the functional exercise level for
daily physical activities.17 Additionally, since the 6MWT is
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Figure 2 Correlates of differences in 6-min walk distance (6MWD) and baseline forced expiratory volume in 1 s (FEV1), functional
residual capacity (FRC), and the BODE index. (A) The BODE index correlated positively with differences in 6MWD between the control
and after the inspiratory muscle training (IMT) maneuver in 16 subjects (upper right panel). However, the percentage predicted FEV1
or percentage predicted FRC did not correlate with differences in 6MWD between the control and after the IMT maneuver.
(B) Percentage predicted FRC correlated positively with differences in the 6MWD between the control and after the thixotropy
conditioning maneuver (middle panel). Percentage predicted FEV1 or the BODE index did not correlate with the differences in 6MWD.
The 6MWD increased after thixotropy conditioning to a greater extent in patients with higher resting FRC.
Thixotropy and the 6-min walk distance 975routinely used for the assessment of exercise capacity in
COPD in Akita City Hospital, this test was well accepted by
the patients and the reproducibility of 6MWD was better
than that of the formal exercise testing.
We found that the preceding thixotropy conditioning of
inspiratory muscles statistically increased the 6MWD by
21.9m (504.3m versus 526.2m). In contrast, the single IMT
maneuver prior to 6MWT did not change the mean 6MWD.
Redelmeier et al. showed that the smallest difference in the
6MWD that is associated with a noticeable clinical difference
in the patients’ perception of exercise performance is a
mean of 54m.18 Accordingly, the improvement in the 6MWD
after single thixotropy conditioning was not clinical sig-niﬁcant. However, correlation analysis indicated that pa-
tients with higher resting FRC showed a larger increase in
the 6MWD after thixotropy conditioning. Patients with
normal resting FRC showed little improvement in the
6MWD. The severity of COPD, graded based on FEV1 or
the BODE index, did not correlate with the changes in the
6MWD. These ﬁndings suggest that thixotropy conditioning
does not always improve exercise capacity in patients with
COPD. Whether patients with COPD will beneﬁt from such
conditioning maneuvers could thus be predicted by their
resting pulmonary characteristics.
The increased 6MWD after thixotropy conditioning may be
explained by the fact that the conditioning causes lung
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creases in IC.4,5 Accordingly, in the present study, thixotropy
conditioning decreased FRC at the start of the 6MWT. That
the 6MWD increased after thixotropy conditioning indicates
that lung deﬂation by thixotropy conditioning prior to
exercise leads to improved exercise tolerance. O’Donnell
et al.19 showed that the extent of dynamic hyperinﬂation
during exercise in COPD correlates best with resting IC,
which indirectly measures FRC. Furthermore, lung deﬂation,
particularly that induced by bronchodilators, has been
shown to increase exercise endurance in patients with
COPD.20,21 O’Donnell et al.21 showed that pretreatment of
salmeterol, an inhaled antiadrenergic bronchodilator, for
2 weeks increases IC at rest and during constant-work-rate
exercise, allowing greater VT expansion when dynamic
hyperinﬂation occurs in patients with COPD. O’Donnell
et al.20 also showed that pretreatment of tiotropium, an
inhaled anticholinergic bronchodilator, for 7–10 days im-
proves lung emptying and thereby reduces absolute lung
volumes at rest and during constant-work-rate exercise in
patients with COPD, suggesting that VT occupies a more
favorable position on the P–V curve of the respiratory
system. They concluded that the improvement in the
effort–displacement ratio throughout exercise reﬂects this
reduced elastic loading. Although the mechanisms that
cause lung deﬂation are different between bronchodilators
and thixotropy conditioning, both cause lung deﬂation.
Thixotropy conditioning prior to the 6MWT should allow
greater VT expansion during the test provided that the
effects of conditioning continues when the levels of
ventilation increase.
While patients with COPD as a whole showed improve-
ment in the 6MWD after thixotropy conditioning, correlation
analysis suggested that those with normal resting FRC
showed little improvement in the 6MWD. Diaz et al.22 found
a signiﬁcant positive correlation between resting IC and
exercise tolerance in COPD patients with tidal expiratory
ﬂow limitations. In contrast, in COPD patients without tidal
expiratory ﬂow limitations, the resting IC played no
signiﬁcant role in exercise capacity. As a result, lung
deﬂation may be an optimal treatment strategy particularly
for patients with tidal expiratory ﬂow limitation. Further-
more, optoelectronic plethysmography (OEP) demonstrated
that exercise limitation in COPD is not necessarily associated
with dynamic hyperinﬂation.23 COPD patients with tidal ﬂow
limitations show dynamic hyperinﬂation during exercise.
However, COPD patients without tidal expiratory ﬂow
limitations do not always show dynamic hyperinﬂation
during exercise (euvolumic patients). In the OEP study,
oxygen consumption is increased by respiratory muscles in
euvolumic patients, which would reduce the oxygen avail-
able to the leg muscles and thereby limit the exercise
capacity. Finally, Diaz et al. showed that COPD patients
without tidal expiratory ﬂow limitations tend to have
lower resting FRC.22 It follows that dynamic hyperinﬂation
may not necessarily be a cause to limit exercise capacity in
COPD patients with lower resting FRC. This explains why
thixotropy conditioning aimed to cause lung deﬂation did
not beneﬁt COPD patients, speciﬁcally those with lower
resting FRC.
Our previous studies on respiratory muscle thixotropy
suggest that muscle thixotropy potentially contributes tolung hyperinﬂation. We have shown that forceful inspiration
at higher lung volumes increases end-expiratory lung volume
of following breath cycles.3,4,6,7 This thixotropic increase in
end-expiratory lung volume may be an additional source of
lung inﬂation in COPD patients with existing lung hyperin-
ﬂation, who must contract their inspiratory muscles with
extra force to obtain sufﬁcient tidal volume at higher lung
volumes. Thixotropy conditioning at lower lung volumes
before exercise may prevent this additional lung inﬂation.
It is important to consider whether limitations in our
methodology inﬂuenced our results. Several limitations of
the present investigation exist. The greatest potential
source of bias exists in the absence of masking. The
investigators were not blinded to the 6MWT results and the
patients were aware of whether they underwent condition-
ing or not. Another limitation was that we used the multiple-
breath helium dilution method to quantify baseline FRC. In
patients with gas trapping, FRC may have been under-
estimated. It could also be argued that a small population
with large variations in age and FEV1 makes it difﬁcult to
extrapolate the results to the general COPD population.
Finally, the patients continued all their medications includ-
ing anticholinergics, b2-agonists, and theophyllines, which
modify IC. However, there was no standard treatment
regimen against which to make comparisons with in the
present study.
In conclusion, the present study shows that thixotropy
conditioning increases self-paced walking distance in pa-
tients with COPD. Patients with higher resting FRC beneﬁted
more from the conditioning in the 6MWT, with greater
distance walked. The conditioning prior to exercise may be
recommended as add-on therapy to be used alongside
bronchodilators or oxygen in these patients.
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